Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Norland Biotech is a biotechnology company specializing in the cultivation, processing, and distribution of microalgae and natural pigments. The company is a leading producer of Spirulina, Chlorella, and Haematococcus pluvialis, as well as high-value extracts like Astaxanthin and Phycocyanin. Their products serve the global food, beverage, dietary supplement, and cosmetic industries. Based in Tianjin, China, the company operates large-scale cultivation bases and manufacturing facilities that adhere to international quality standards. They maintain various organic certifications, including USDA and EU Organic, to facilitate international trade. The company's expertise lies in advanced extraction technologies and sustainable algae farming.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Norland Biotech.